Author

Kai Sutterby

University of ArizonaORCID 0009-0002-0548-9864Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Assay:bulk RNA-seq· 1 Research Focus:cancer & tumor microenvironment· 1 Research Focus:cell type annotation· 1 Research Focus:cell-cell communication· 1 Research Focus:differential expression· 1 Approach:experimental assay· 1 Organism:mouse· 1 Approach:statistical model· 1

Frequent Co-Authors

Alejandro Recio‐BoilesiD· 1 shared Alex Patrick FarrelliD· 1 shared Amber N. ClementsiD· 1 shared Andrea L. CasillasiD· 1 shared Anne E. CressiD· 1 shared Caitlyn E. FloresiD· 1 shared Chadi NabhaniD· 1 shared Elisabeth I. HeathiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Alejandro Recio‐BoilesORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

Inhibition of PIM kinase in tumor associated macrophages suppresses inflammasome 1 activation and sensitizes prostate cancer to immunotherapy

Amber N. Clements, Andrea L. Casillas, Caitlyn E. Flores, Hope Liou, Rachel K. Toth, Shailender Singh Chauhan, Kai Sutterby, Sachin Kumar Deshmukh, Sharon Wu, Joanne Xiu, Alex Patrick Farrell, Milan Radovich, Chadi Nabhan, Elisabeth I. Heath, Rana R. McKay, , Noel A. Warfel

This study shows that inhibiting PIM kinases in tumor-associated macrophages reduces inflammasome activation and improves response to immunotherapy in prostate cancer.

Cancer Immunology Research · Feb 21, 2025Peer-reviewedCancer Biology